MedTrace Logo

Drug-Drug Interaction Study Between Henagliflozin Proline and Hydrochlorothiazide

NCT06083116 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2023-10-13

No results posted yet for this study

Summary

A single-center, single-arm, open-label, multi-dose, three-period study was conducted in healthy Chinese volunteers.

Conditions

  • Diabetes in Adults

Interventions

DRUG

Hydrochlorothiazide、Henagliflozin Proline

Hydrochlorothiazide and Henagliflozin Proline

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-28
Primary Completion
2019-10-10
Completion
2019-10-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06083116 on ClinicalTrials.gov